Latest filing published 02 Jun 2008 for RespireRx Pharmaceuticals Inc., €88.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James H. Coleman: trading record in brief
All filings by James H. Coleman on record concern RespireRx Pharmaceuticals Inc. In total, 7 filings cover trades dated from 7 November 2007 to 30 May 2008.
Purchases make up the whole of the open-market record (5 purchases, €38k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants.
The median purchase comes to €8,270.
The record was last updated on 2 June 2008 with a share grant (€88) in RespireRx Pharmaceuticals Inc. The most recent open-market purchase was published on 19 November 2007, 6,930 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James H. Coleman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 185 shares@ US$0.74Common StockSEC:0001181431-08-035908:0
- 7,005 shares@ US$0.78Common StockSEC:0001181431-08-035908:1
- 4,650 shares@ US$0.48Common StockSEC:0001181431-07-070411:0Canonical exit: 17 Feb 2008 (T+90)
- 24,700 shares@ US$0.49Common StockSEC:0001181431-07-070186:0Canonical exit: 14 Feb 2008 (T+90)
- 42,400 shares@ US$0.49Common StockSEC:0001181431-07-068481:0Canonical exit: 10 Feb 2008 (T+90)
- 40,000 shares@ US$0.49Common StockSEC:0001181431-07-068074:0Canonical exit: 5 Feb 2008 (T+90)
- 100 shares@ US$0.48Common StockSEC:0001181431-07-068074:1Canonical exit: 7 Feb 2008 (T+90)
7 of 7 declarations